The CDKN1B gene encodes the cyclin-dependent kinase inhibitor p27KIP1, an atypical tumor suppressor playing a key role in cell cycle regulation, cell proliferation, and differentiation. Impaired p27KIP1 expression and/or localization are often observed in tumor cells, further confirming its central role in regulating the cell cycle. Recently, germline mutations in CDKN1B have been associated with the inherited multiple endocrine neoplasia syndrome type 4, an autosomal dominant syndrome characterized by varying combinations of tumors affecting at least two endocrine organs. In this study we identified a 4-bp deletion in a highly conserved regulatory upstream ORF (uORF) in the 5′UTR of the CDKN1B gene in a patient with a pituitary adenoma and a well-differentiated pancreatic neoplasm. This deletion causes the shift of the uORF termination codon with the consequent lengthening of the uORF–encoded peptide and the drastic shortening of the intercistronic space. Our data on the immunohistochemical analysis of the patient's pancreatic lesion, functional studies based on dual-luciferase assays, site-directed mutagenesis, and on polysome profiling show a negative influence of this deletion on the translation reinitiation at the CDKN1B starting site, with a consequent reduction in p27KIP1 expression. Our findings demonstrate that, in addition to the previously described mechanisms leading to reduced p27KIP1 activity, such as degradation via the ubiquitin/proteasome pathway or non-covalent sequestration, p27KIP1 activity can also be modulated by an uORF and mutations affecting uORF could change p27KIP1 expression. This study adds the CDKN1B gene to the short list of genes for which mutations that either create, delete, or severely modify their regulatory uORFs have been associated with human diseases.
Vyšlo v časopise: A Novel Mutation in the Upstream Open Reading Frame of the Gene Causes a MEN4 Phenotype. PLoS Genet 9(3): e32767. doi:10.1371/journal.pgen.1003350 Kategorie: Research Article prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1003350
1. SherrCJ, RobertsJM (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13 : 1501–1512.
2. SherrCJ, RobertsJM (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9 : 1149–1163.
3. ReedSI, BaillyE, DulicV, HengstL, ResnitzkyD, et al. (1994) G1 control in mammalian cells. J Cell Sci Suppl 18 : 69–73.
4. ChuIM, HengstL, SlingerlandJM (2008) The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev Cancer 8 : 253–267.
5. BorrielloA, CucciollaV, OlivaA, ZappiaV, Della RagioneF (2007) p27Kip1 metabolism: a fascinating labyrinth. Cell Cycle 6 : 1053–1061.
6. SlingerlandJ, PaganoM (2000) Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol 183 : 10–17.
7. Le SageC, NagelR, AgamiR (2007) Diverse ways to control p27(Kip1) function: miRNAs come into play. Cell Cycle 6 : 2742–2749.
8. AgarwalSK, MateoCM, MarxSJ (2009) Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states. J Clin Endocrinol Metab 94 : 1826–1834.
9. MalangaD, De GisiS, RiccardiM, ScrimaM, De MarcoC, et al. (2012) Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1 (CDKN1B) in a Spanish patient with multiple endocrine neoplasia-like phenotype. Eur J Endocrinol 166 : 551–560.
10. KullmannM, GöpfertU, SieweB, HengstL (2002) ELAV/Hu proteins inhibit p27 translation via an IRES element in the p27 5′UTR. Genes Dev 16 : 3087–3099.
11. GöpfertU, KullmannM, HengstL (2003) Cell cycle-dependent translation of p27 involves a responsive element in its 5′-UTR that overlaps with a uORF. Hum Mol Genet 12 : 1767–1779.
12. MiskiminsWK, WangG, HawkinsonM, MiskiminsR (2001) Control of cyclin-dependent kinase inhibitor p27 expression by cap-independent translation. Mol Cell Biol 21 : 4960–4967.
13. YoonA, PengG, BrandenburgerY, ZolloO, XuW, et al. (2006) Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita. Science 312 : 902–906.
14. PellegataNS, Quintanilla-MartinezL, SiggelkowH, SamsonE, BinkK, et al. (2006) Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci USA 103 : 15558–15563.
15. FalchettiA, MariniF, LuziE, TonelliF, BrandiML (2008) Multiple endocrine neoplasms. Best Pract Res Clin Rheumatol 22 : 149–163.
16. GeorgitsiM, RaitilaA, KarhuA, van der LuijtRB, AalfsCM, et al. (2007) Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia. J Clin Endocrinol Metab 92 : 3321–3325.
17. MolatoreS, MarinoniI, LeeM, PulzE, AmbrosioMR, et al. (2010) A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization. Hum Mutat 31: E1825–1835.
18. Costa-GudaJ, MarinoniI, MolatoreS, PellegataNS, ArnoldA (2011) Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas. J Clin Endocrinol Metab 96: E701–706.
19. MorrisDR (2000) GeballeAP (2000) Upstream open reading frames as regulators of mRNA translation. Mol Cell Biol 20 : 8635–8642.
20. MatsuiM, YachieN, OkadaY, SaitoR, TomitaM (2007) Bioinformatic analysis of post-transcriptional regulation by uORF in human and mouse. FEBS Lett 581 : 4184–4188.
21. LuukkonenBG, TanW, SchwartzS (1995) Efficiency of reinitiation of translation on human immunodeficiency virus type 1 mRNAs is determined by the length of the upstream open reading frame and by intercistronic distance. J Virol 69 : 4086–4094.
22. KozakM (2001) Constraints on reinitiation of translation in mammals. Nucleic Acids Res 29 : 5226–5232.
23. LarreaMD, WanderSA, SlingerlandJM (2009) p27 as Jekyll and Hyde: regulation of cell cycle and cell motility. Cell Cycle 8 : 3455–3461.
24. FeroML, RandelE, GurleyKE, RobertsJM, KempCJ (1998) The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature 396 : 177–180.
25. IgrejaS, ChahalHS, AkkerSA, GueorguievM, PopovicV, et al. (2009) Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations. Clin Endocrinol (Oxf) 70 : 259–264.
26. CalvoSE, PagliariniDJ, MoothaVK (2009) Upstream open reading frames cause widespread reduction of protein expression and are polymorphic among humans. Proc Natl Acad Sci USA 106 : 7507–7512.
27. CroweML, WangXQ, RothnagelJA (2006) Evidence for conservation and selection of upstream open reading frames suggests probable encoding of bioactive peptides. BMC Genomics 26 : 7–16.
28. JohannesG, SarnowP (1998) Cap-independent polysomal association of natural mRNAs encoding c-myc, BiP, and eIF4G conferred by internal ribosome entry sites. RNA 4 : 1500–1513.
29. OzawaA, AgarwalSK, MateoCM, BurnsAL, RiceTS, et al. (2007) The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations. J Clin Endocrinol Metab 92 : 1948–1951.
30. ScheperGC, van der KnaapMS, ProudCG (2007) Translation matters: protein synthesis defects in inherited disease. Nat Rev Genet 8 : 711–723.
31. WiestnerA, SchlemperRJ, van der MaasAP, SkodaRC (1998) An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia. Nat Genet 18 : 49–52.
32. LiuL, DilworthD, GaoL, MonzonJ, SummersA, et al. (1999) Mutation of the CDKN2A 5′ UTR creates an aberrant initiation codon and predisposes to melanoma. Nat Genet 21 : 128–132.
33. WenY, LiuY, XuY, ZhaoY, HuaR, et al. (2009) Loss-of-function mutations of an inhibitory upstream ORF in the human hairless transcript cause Marie Unna hereditary hypotrichosis. Nat Genet 41 : 228–233.
34. BeffagnaG, OcchiG, NavaA, VitielloL, DitadiA, et al. (2005) Regulatory mutations in transforming growth factor-beta 3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc Res 65 : 366–373.
35. ZhouW (2006) SongW (2006) Leaky scanning and reinitiation regulate BACE1 gene expression. Mol Cell Biol 26 : 3353–3364.
36. SpevakCC, ParkEH, GeballeAP, PelletierJ, SachsMS (2006) her-2 upstream open reading frame effects on the use of downstream initiation codons. Biochem Biophys Res Commun 350 : 834–841.
37. WethmarK, SminkJJ, LeutzA (2010) Upstream open reading frames: molecular switches in (patho)physiology. Bioessays 32 : 885–893.
38. KozakM (1991) An analysis of vertebrate mRNA sequences: intimations of translational control. J Cell Biol 115 : 887–903.
39. MehtaA, TrottaCR, PeltzSW (2006) Derepression of the Her-2 uORF is mediated by a novel post-transcriptional control mechanism in cancer cells. Genes Dev 20 : 939–953.
40. ThakkerRV, NeweyPJ, WallsGV, BilezikianJ, DralleH, et al. (2012) Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1). J Clin Endocrinol Metab 97 : 2990–3011.
41. OcchiG, TrivellinG, CeccatoF, De LazzariP, GiorgiG, et al. (2010) Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasia. Eur J Endocrinol 163 : 369–376.
42. YeS, DhillonS, KeX, CollinsAR, DayIN (2001) An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res 29: E88–8.
43. ChomczynskiP, SacchiN (2006) The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nat Protoc 1 : 581–585.
44. Quintanilla-MartinezL, KremerM, SpechtK, Calzada-WackJ, NathrathM, et al. (2003) Analysis of signal transducer and activator of transcription 3 (Stat 3) pathway in multiple myeloma: Stat 3 activation and cyclin D1 dysregulation are mutually exclusive events. Am J Pathol 162 : 1449–1461.
Zvýšte si kvalifikáciu online z pohodlia domova
Nemáte účet? Registrujte sa
Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.
